Mechanical unloading of the rat heart involves marked changes in the protein kinase-phosphatase balance

Journal of Molecular and Cellular Cardiology

Volumn 45, Issue 6, 2008, Pages 846-852

  Schwoerer, Alexander P ^a   Neuber, Christiane ^a   Schmechel, Ariane ^a   Melnychenko, Ivan ^a   Mearini, Giulia ^a   Boknik, Peter ^b   Kirchhefer, Uwe ^b   Schmitz, Wilhelm ^b   Ehmke, Heimo ^a   Eschenhagen, Thomas ^a   El Armouche, Ali ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Cardiac kinases; Cardiac phosphatases; Left ventricular unloading; Phospholamban; Troponin 1

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CALCIUM ION; CYCLIC AMP DEPENDENT PROTEIN KINASE; MESSENGER RNA; PHOSPHOLAMBAN; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE; PROTEIN KINASE (CALCIUM,CALMODULIN) II; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; TROPONIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ENZYME ASSAY; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE MASS; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE REMODELING; IMMUNOBLOTTING; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; CALCIUM-BINDING PROTEINS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HEART TRANSPLANTATION; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; MALE; MUSCLE PROTEINS; MYOCARDIUM; PHOSPHORYLATION; PROTEIN PHOSPHATASE 1; PROTEIN PHOSPHATASE 2; RATS; RATS, INBRED LEW; TRANSPLANTATION, HOMOLOGOUS; TROPONIN I;

ANIMALIA; RATTUS;

EID: 55649124299     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2008.09.003     Document Type: Article

References (63)

1. Lohse M.J., Engelhardt S., and Eschenhagen T. What is the role of beta-adrenergic signaling in heart failure?. Circ. Res. 93 (2003) 896-906
2. Rapundalo S.T. Cardiac protein phosphorylation: functional and pathophysiological correlates. Cardiovasc. Res. 38 (1998) 559-588
3. MacLennan D.H., and Kranias E.G. Phospholamban: a crucial regulator of cardiac contractility. Nat. Rev., Mol. Cell. Biol. 4 (2003) 566-577
4. Kobayashi T., and Solaro R.J. Calcium, thin filaments, and the integrative biology of cardiac contractility. Annu. Rev. Physiol. 67 (2005) 39-67
5. Cazorla O., Szilagyi S., Vignier N., Salazar G., Kramer E., Vassort G., et al. Length and protein kinase a modulations of myocytes in cardiac myosin binding protein C-deficient mice. Cardiovasc. Res. 69 (2006) 370-380
6. Winegrad S. Myosin binding protein C, a potential regulator of cardiac contractility. Circ. Res. 86 (2000) 6-7
7. Carrier L. Cardiac myosin-binding protein C in the heart. Arch. Mal. Coeur Vaiss. 100 (2007) 238-243
8. 2+ sensitivity of force and activation dependence of the kinetics of myocardial force development. Am. J. Physiol, Heart Circ. Physiol. 287 (2004) H2712-H2718
9. Patel J.R., Diffee G.M., Huang X.P., and Moss R.L. Phosphorylation of myosin regulatory light chain eliminates force-dependent changes in relaxation rates in skeletal muscle. Biophys. J. 74 (1998) 360-368
10. Herzig S., and Neumann J. Effects of serine/threonine protein phosphatases on ion channels in excitable membranes. Physiol. Rev. 80 (2000) 173-210
11. Carr A.N., Schmidt A.G., Suzuki Y., del Monte F., Sato Y., Lanner C., et al. Type 1 phosphatase, a negative regulator of cardiac function. Mol. Cell. Biol. 22 (2002) 4124-4135
12. Gergs U., Boknik P., Buchwalow I., Fabritz L., Matus M., Justus I., et al. Overexpression of the catalytic subunit of protein phosphatase 2A impairs cardiac function. J. Biol. Chem. 279 (2004) 40827-40834
13. DeRose Jr. J.J., Umana J.P., Argenziano M., Catanese K.A., Gardocki M.T., Flannery M., et al. Implantable left ventricular assist devices provide an excellent outpatient bridge to transplantation and recovery. J. Am. Coll. Cardiol. 30 (1997) 1773-1777
14. Ogletree-Hughes M.L., Stull L.B., Sweet W.E., Smedira N.G., McCarthy P.M., and Moravec C.S. Mechanical unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in the failing human heart. Circulation 104 (2001) 881-886
15. Heerdt P.M., Holmes J.W., Cai B., Barbone A., Madigan J.D., Reiken S., et al. Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure. Circulation 102 (2000) 2713-2719
16. Margulies K.B. Reversal mechanisms of left ventricular remodeling: lessons from left ventricular assist device experiments. J. Card. Fail. 8 (2002) S500-505
17. 2+ transport in atrophic heart transplants in rat. Am. J. Physiol. 251 (1986) H941-H948
18. Minatoya Y., Ito K., Kagaya Y., Asaumi Y., Takeda M., Nakayama M., et al. Depressed contractile reserve and impaired calcium handling of cardiac myocytes from chronically unloaded hearts are ameliorated with the administration of physiological treatment dose of T3 in rats. Acta Physiol. (Oxf) 189 (2007) 221-231
19. Ito K., Nakayama M., Hasan F., Yan X., Schneider M.D., and Lorell B.H. Contractile reserve and calcium regulation are depressed in myocytes from chronically unloaded hearts. Circulation 107 (2003) 1176-1182
20. Klotz S., Barbone A., Reiken S., Holmes J.W., Naka Y., Oz M.C., et al. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties. J. Am. Coll. Cardiol. 45 (2005) 668-676
21. 2+ channel density and regulation are altered in failing human ventricular myocytes and recover after support with mechanical assist devices. Circ. Res. 91 (2002) 517-524
22. Milting H., Scholz C., Arusoglu L., Freitag M., Cebulla R., Jaquet K., et al. Selective upregulation of beta1-adrenergic receptors and dephosphorylation of troponin I in end-stage heart failure patients supported by ventricular assist devices. J. Mol. Cell. Cardiol. 41 (2006) 441-450
23. Depre C., Shipley G.L., Chen W., Han Q., Doenst T., Moore M.L., et al. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy. Nat. Med. 4 (1998) 1269-1275
24. Schwoerer AP, Melnychenko I, Goltz D, Hedinger N, Broichhausen I, El-Armouche A, et al., Unloaded rat hearts in vivo express a hypertrophic phenotype of cardiac repolarization. J. Mol. Cell. Cardiol. in press.
25. El-Armouche A., Rau T., Zolk O., Ditz D., Pamminger T., Zimmermann W.H., et al. Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes. FASEB J. 17 (2003) 437-439
26. Grimm M., Mahnecke N., Soja F., El-Armouche A., Haas P., Treede H., et al. The MLCK-mediated alpha1-adrenergic inotropic effect in atrial myocardium is negatively modulated by PKCepsilon signaling. Br. J. Pharmacol. 148 (2006) 991-1000
27. El-Armouche A., Singh J., Naito H., Wittkopper K., Didie M., Laatsch A., et al. Adenovirus-delivered short hairpin RNA targeting PKCalpha improves contractile function in reconstituted heart tissue. J. Mol. Cell. Cardiol. 43 (2007) 371-376
28. 2+/calmodulin-dependent protein kinase in failing and nonfailing human hearts. Cardiovasc. Res. 42 (1999) 254-261
29. 2+ handling in human chronic atrial fibrillation. Circulation 114 (2006) 670-680
30. Sharma S., Ying J., Razeghi P., Stepkowski S., and Taegtmeyer H. Atrophic remodeling of the transplanted rat heart. Cardiology 105 (2006) 128-136
31. Geenen D.L., Malhotra A., Buttrick P.M., and Scheuer J. Ventricular pacing attenuates but does not reverse cardiac atrophy and an isomyosin shift in the rat heart. Am. J. Physiol. 267 (1994) H2149-H2154
32. 2+/calmodulin-dependent protein kinase II. Biochem. J. 364 (2002) 593-611
33. Kolar F., MacNaughton C., Papousek F., and Korecky B. Systolic mechanical performance of heterotopically transplanted hearts in rats treated with cyclosporin. Cardiovasc. Res. 27 (1993) 1244-1247
34. Kolar F., MacNaughton C., Papousek F., Korecky B., and Rakusan K. Changes in calcium handling in atrophic heterotopically isotransplanted rat hearts. Basic Res. Cardiol. 90 (1995) 475-481
35. 2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart. Cardiovasc. Res. 73 (2007) 631-640
36. 2+/calmodulin-dependent protein kinase in failing and nonfailing human myocardium. Circ. Res. 84 (1999) 713-721
37. Kohlhaas M., Zhang T., Seidler T., Zibrova D., Dybkova N., Steen A., et al. Increased sarcoplasmic reticulum calcium leak but unaltered contractility by acute CaMKII overexpression in isolated rabbit cardiac myocytes. Circ. Res. 98 (2006) 235-244
38. Hasenfuss G., and Pieske B. Calcium cycling in congestive heart failure. J. Mol. Cell. Cardiol. 34 (2002) 951-969
39. 2+-calmodulin-dependent protein kinases. J. Biol. Chem. 259 (1984) 15587-15596
40. McDonough J.L., Arrell D.K., and Van Eyk J.E. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ. Res. 84 (1999) 9-20
41. Decker R.S., Decker M.L., Kulikovskaya I., Nakamura S., Lee D.C., Harris K., et al. Myosin-binding protein C phosphorylation, myofibril structure, and contractile function during low-flow ischemia. Circulation 111 (2005) 906-912
42. Sadayappan S., Osinska H., Klevitsky R., Lorenz J.N., Sargent M., Molkentin J.D., et al. Cardiac myosin binding protein C phosphorylation is cardioprotective. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 16918-16923
43. Razeghi P., Volpini K.C., Wang M.E., Youker K.A., Stepkowski S., and Taegtmeyer H. Mechanical unloading of the heart activates the calpain system. J. Mol. Cell. Cardiol. 42 (2007) 449-452
44. Neumann J., Eschenhagen T., Jones L.R., Linck B., Schmitz W., Scholz H., et al. Increased expression of cardiac phosphatases in patients with end-stage heart failure. J. Mol. Cell. Cardiol. 29 (1997) 265-272
45. Linck B., Boknik P., Knapp J., Kikuchi K., Luss H., Muller F.U., et al. Functional properties of the rat phosphatase 1alpha promoter. Mol. Cell. Biochem. 223 (2001) 123-129
46. Razeghi P., Sharma S., Ying J., Li Y.P., Stepkowski S., Reid M.B., et al. Atrophic remodeling of the heart in vivo simultaneously activates pathways of protein synthesis and degradation. Circulation 108 (2003) 2536-2541
47. Rajabi M., Kassiotis C., Razeghi P., and Taegtmeyer H. Return to the fetal gene program protects the stressed heart: a strong hypothesis. Heart Fail. Rev. 12 (2007) 331-343
48. Gombosova I., Boknik P., Kirchhefer U., Knapp J., Luss H., Muller F.U., et al. Postnatal changes in contractile time parameters, calcium regulatory proteins, and phosphatases. Am. J. Physiol. 274 (1998) H2123-H2132
49. Boknik P., Fockenbrock M., Herzig S., Knapp J., Linck B., Luss H., et al. Protein phosphatase activity is increased in a rat model of long-term beta-adrenergic stimulation. Naunyn-Schmiedeberg's Arch. Pharmacol. 362 (2000) 222-231
50. El-Armouche A., Gocht F., Jaeckel E., Wittkopper K., Peeck M., and Eschenhagen T. Long-term beta-adrenergic stimulation leads to downregulation of protein phosphatase inhibitor-1 in the heart. Eur. J. Heart Fail. 9 (2007) 1077-1080
51. Gupta R.C., Mishra S., Rastogi S., Imai M., Habib O., and Sabbah H.N. Cardiac SR-coupled PP1 activity and expression are increased and inhibitor 1 protein expression is decreased in failing hearts. Am. J. Physiol, Heart Circ. Physiol. 285 (2003) H2373-H2381
52. Ceulemans H., and Bollen M. Functional diversity of protein phosphatase-1, a cellular economizer and reset button. Physiol. Rev. 84 (2004) 1-39
53. Pathak A., del M.F., Zhao W., Schultz J.E., Lorenz J.N., Bodi I., et al. Enhancement of cardiac function and suppression of heart failure progression by inhibition of protein phosphatase 1. Circ. Res. 96 (2005) 756-766
54. Kirchhefer U., Baba H.A., Boknik P., Breeden K.M., Mavila N., Bruchert N., et al. Enhanced cardiac function in mice overexpressing protein phosphatase inhibitor-2. Cardiovasc. Res. 68 (2005) 98-108
55. Yamada M., Ikeda Y., Yano M., Yoshimura K., Nishino S., Aoyama H., et al. Inhibition of protein phosphatase 1 by inhibitor-2 gene delivery ameliorates heart failure progression in genetic cardiomyopathy. FASEB J 20 (2006) 1197-1199
56. Auger-Messier M., York A., Naim A.C., and Molkentin J.D. Cardiac-specific deletion of protein phosphatase 1α leads to reduced myocardial function. Circ. Res. 101 (2007) e62
57. Barbone A., Holmes J.W., Heerdt P.M., The A.H., Naka Y., Joshi N., et al. Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling. Circulation 104 (2001) 670-675
58. Maybaum S., Mancini D., Xydas S., Starling R.C., Aaronson K., Pagani F.D., et al. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD working group. Circulation 115 (2007) 2497-2505
59. Kuhn M., Voss M., Mitko D., Stypmann J., Schmid C., Kawaguchi N., et al. Left ventricular assist device support reverses altered cardiac expression and function of natriuretic peptides and receptors in end-stage heart failure. Cardiovasc. Res. 64 (2004) 308-314
60. Park S.J., Zhang J., Ye Y., Ormaza S., Liang P., Bank A.J., et al. Myocardial creatine kinase expression after left ventricular assist device support. J. Am. Coll. Cardiol. 39 (2002) 1773-1779
61. Razeghi P., Bruckner B.A., Sharma S., Youker K.A., Frazier O.H., and Taegtmeyer H. Mechanical unloading of the failing human heart fails to activate the protein kinase B/Akt/glycogen synthase kinase-3beta survival pathway. Cardiology 100 (2003) 17-22
62. Doenst T., Bugger H., Leippert S., Barleon B., Marme D., and Beyersdorf F. Differential gene expression in response to ventricular unloading in rat and human myocardium. Thorac. Cardiovasc. Surg. 54 (2006) 381-387
63. Razeghi P., Buksinska-Lisik M., Palanichamy N., Stepkowski S., Frazier O.H., and Taegtmeyer H. Transcriptional regulators of ribosomal biogenesis are increased in the unloaded heart. FASEB J. 20 (2006) 1090-1096